Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Panagiotis Kratimenos, Ioannis Koutroulis, Vasiliki Syriopoulou, Christina Michailidi, Maria Delivoria-Papadopoulos, Jerzy Klijanienko & Stamatios Theocharis. (2017) FAK-Src-paxillin system expression and disease outcome in human neuroblastoma. Pediatric Hematology and Oncology 34:4, pages 221-230.
Read now
Read now
Articles from other publishers (17)
Dan Ma, Ping Liu, Chujiao Hu, Zhen Zhou, Ping Wang, Yan Wang, Yaming Zhang, Yunsheng Ran, Pinghao Li, Jiangyuan Zhao, Jishi Wang, Chengliang Zhang & Lei Tang. (2022) Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia. Oncogene 42:2, pages 124-137.
Crossref
Crossref
Shoucheng Du, John J. Alvarado, Thomas E. Wales, Jamie A. Moroco, John R. Engen & Thomas E. Smithgall. (2022) ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase, Fgr. Structure 30:11, pages 1508-1517.e3.
Crossref
Crossref
Samira Nafar, Negar Nouri, Maedeh Alipour, Jafar Fallahi, Fateme Zare & Seyed Mohammad Bagher Tabei. (2023) Exosome as a target for cancer treatment. Journal of Investigative Medicine 70:5, pages 1212-1218.
Crossref
Crossref
Mona G. El-Sisi, Sara M. Radwan, Alia M. Saeed & Hala O. El-Mesallamy. (2021) Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival. Molecular and Cellular Biochemistry 476:5, pages 1949-1963.
Crossref
Crossref
Kalpana K. Bhanumathy, Amrutha Balagopal, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Andrew Freywald & Vincenzo Giambra. (2021) Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia. Cancers 13:2, pages 184.
Crossref
Crossref
Lore De Kock & Kathleen Freson. (2020) The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes. Medicina 56:12, pages 633.
Crossref
Crossref
Erwan Beauchamp, Megan C. Yap, Aishwarya Iyer, Maneka A. Perinpanayagam, Jay M. Gamma, Krista M. Vincent, Manikandan Lakshmanan, Anandhkumar Raju, Vinay Tergaonkar, Soo Yong Tan, Soon Thye Lim, Wei-Feng Dong, Lynne M. Postovit, Kevin D. Read, David W. Gray, Paul G. Wyatt, John R. Mackey & Luc G. Berthiaume. (2020) Targeting N-myristoylation for therapy of B-cell lymphomas. Nature Communications 11:1.
Crossref
Crossref
Lihui Zhu, Chengyong Qin, Tao Li, Xiaomin Ma, Yumin Qiu, Yueke Lin, Dapeng Ma, Zhenzhi Qin, Caiyu Sun, Xuecheng Shen, Yunxue Zhao & Lihui Han. (2019) The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein. Cell Death & Differentiation 27:6, pages 1819-1831.
Crossref
Crossref
Ana Azevedo, Susana Silva & José Rueff. 2019. Tyrosine Kinases as Druggable Targets in Cancer. Tyrosine Kinases as Druggable Targets in Cancer.
Ashleigh Parkin, Jennifer Man, Paul Timpson & Marina Pajic. (2019) Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. The FEBS Journal 286:18, pages 3510-3539.
Crossref
Crossref
Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, Amélie V. Guitart, Noël Milpied, Arnaud Pigneux, Isabelle Vigon, Jean-Max Pasquet & Pierre-Yves Dumas. (2019) Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?. International Journal of Molecular Sciences 20:14, pages 3429.
Crossref
Crossref
Youngdae Gwon, Seo-Hyun Kim, Hyun Tae Kim, Tae-In Kam, Jisu Park, Bitna Lim, Hyunju Cha, Ho-Jin Chang, Yong Rae Hong & Yong-Keun Jung. (2018) Amelioration of amyloid β‐FcγRIIb neurotoxicity and tau pathologies by targeting LYN. The FASEB Journal 33:3, pages 4300-4313.
Crossref
Crossref
Kodappully S. Siveen, Kirti S. Prabhu, Iman W. Achkar, Shilpa Kuttikrishnan, Sunitha Shyam, Abdul Q. Khan, Maysaloun Merhi, Said Dermime & Shahab Uddin. (2018) Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products. Molecular Cancer 17:1.
Crossref
Crossref
Kexin Shen, Jamie A. Moroco, Ravi K. PatelHaibin Shi, John R. Engen, Heather R. Dorman & Thomas E. Smithgall. (2018) The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation. Science Signaling 11:553.
Crossref
Crossref
Xing Shen, Shuang Xing, Lu Zhang, Fangmin Wang, Hongling Ou, Yajun Shan, He Xiao, Guolin Xiong, Xinru Wang, Qinshi Zhao, Yuwen Cong & Zuyin Yu. (2018) Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn. Biochemical and Biophysical Research Communications 502:1, pages 110-115.
Crossref
Crossref
Gahana Advani, Ya Chee Lim, Bruno Catimel, Daisy Sio Seng Lio, Nadia L. Y. Ng, Anderly C. Chüeh, Mai Tran, Mohd Ishtiaq Anasir, Heather Verkade, Hong-Jian Zhu, Benjamin E. Turk, Thomas E. Smithgall, Ching-Seng Ang, Michael Griffin & Heung-Chin Cheng. (2017) Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Cell Communication and Signaling 15:1.
Crossref
Crossref
Ilaria Laurenzana, Antonella Caivano, Francesco La Rocca, Stefania Trino, Luciana De Luca, Francesca D’Alessio, Silvia Schenone, Geppino Falco, Maurizio Botta, Luigi Del Vecchio & Pellegrino Musto. (2016) A Pyrazolo[3,4-d]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological Malignancies. Frontiers in Pharmacology 7.
Crossref
Crossref